Latest filing published 05 Jan 2026 for Oramed Pharmaceuticals INC..
Insider track record
No signal scores available.
Benjamin Shapiro: trading record in brief
All filings by Benjamin Shapiro on record concern Oramed Pharmaceuticals Inc. Between 1 May 2023 and 31 December 2025, the trades on record add up to 7 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 5 January 2026 came the latest disclosure, a share grant in Oramed Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Benjamin Shapiro
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,000 sharesCommon StockSEC:0001213900-26-001277:0
- 30,000 sharesCommon StockSEC:0001213900-25-052618:0
- 30,000 sharesCommon StockSEC:0001209191-24-001131:0
- 20,000 sharesCommon StockSEC:0001209191-23-026306:0
4 of 4 declarations
